ERIS Lifesciences Ltd Quarterly Results

Gross Sales

790.15

771.56

702.6

722.12

738.95

Excise Duty

0

0

0

0

0

Net Sales

790.15

771.56

702.6

722.12

738.95

Other Operating Income

2.26

1.44

2.7

5.33

2.22

Other Income

3.09

3.58

8.01

4.22

4.55

Total Income

795.5

776.58

713.31

731.67

745.72

Total Expenditure

504.2

496.29

452.91

477.14

476.66

PBIDT

291.3

280.29

260.4

254.53

269.06

Interest

49.55

48.68

54.28

57.17

59.47

PBDT

241.75

231.61

206.12

197.36

209.59

Depreciation

69.08

70.51

77.25

81

80.48

Minority Interest Before NP

0

0

0

0

0

Tax

71.18

56.31

31.39

24.86

30.25

Deferred Tax

-32.98

-20.31

-4.87

4.44

2.51

Reported Profit After Tax

134.47

125.1

102.35

87.06

96.35

Minority Interest After NP

14.28

7.11

8.51

3.3

4.76

Net Profit after Minority Interest

120.19

117.99

93.84

83.76

91.59

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

120.19

117.99

93.84

83.76

91.59

EPS (Unit Curr.)

8.82

8.66

6.9

6.16

6.73

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

735

0

Equity

13.62

13.62

13.62

13.61

13.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.86

36.32

37.06

35.24

36.41

PBDTM(%)

30.59

30.01

29.33

27.33

28.36

PATM(%)

17.01

16.21

14.56

12.05

13.03